CMP-001 in Combination with Nivolumab in Subjects with Advanced Melanoma

Trial Identifier: CMP-001-010
Sponsor: Regeneron Pharmaceuticals
Collaborator:
Bristol Myers Squibb
Start Date: March 2021
Primary Completion Date: February 2024
Study Completion Date: February 2024
Condition: Skin Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
United States, Arizona Phoenix, Arizona, United States, 85054
United States, California Duarte, California, United States, 91010
United States, California Los Angeles, California, United States, 90095
United States, California San Marcos, California, United States, 92069
United States, Colorado Denver, Colorado, United States, 80204
United States, Connecticut Hartford, Connecticut, United States, 06106
United States, Florida Jacksonville, Florida, United States, 32204
United States, Florida Orlando, Florida, United States, 32806
United States, Florida Weston, Florida, United States, 33331
United States, Georgia Athens, Georgia, United States, 30607
United States, Georgia Atlanta, Georgia, United States, 30322
United States, Illinois Chicago, Illinois, United States, 60611
United States, Iowa Iowa City, Iowa, United States, 52242
United States, Kentucky Louisville,, Kentucky, United States, 40202
United States, Massachusetts Boston, Massachusetts, United States, 02114
United States, New York New York, United States, 10032
United States, New York New York, United States, 10065
United States, North Carolina Durham, North Carolina, United States, 27710
United States, Ohio Columbus, Ohio, United States, 43220
United States, Oklahoma Oklahoma City, Oklahoma, United States, 73104
United States, Pennsylvania Philadelphia, Pennsylvania, United States, 19107
United States, Pennsylvania Pittsburgh, Pennsylvania, United States, 15232
United States, Texas Dallas, Texas, United States, 75246
United States, Utah Salt Lake City, Utah, United States, 84112
United States, Washington Seattle, Washington, United States, 98109